Cefazolin/doxorubicin/ethiodized oilTumour lysis syndrome and acute renal failure: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1543卷 / 1期

关键词：

D O I：

10.1007/s40278-015-8684-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：60 / 60

相关论文

共 50 条

[1] Doxorubicin/ethiodized oilTumour lysis syndrome: 2 case reports
Reactions Weekly, 2010, 1297 (1) : 23 - 23
[2] Epirubicin/ethiodized-oilTumour lysis syndrome: case report
Reactions Weekly, 2022, 1897 (1) : 171 - 171
[3] Doxorubicin/ethiodized oilAcute tumour lysis syndrome: case report
Reactions Weekly, 2011, 1343 (1) : 16 - 16
[4] TrastuzumabTumour lysis syndrome and acute renal failure: case report
Reactions Weekly, 2015, 1578 (1) : 285 - 285
[5] MethylprednisoloneTumour lysis syndrome and acute renal failure: case report
Reactions Weekly, 2003, 959 (1) : 12 - 12
[6] BendamustineTumour lysis syndrome and acute renal failure: case report
Reactions Weekly, 2015, 1538 (1) : 43 - 43
[7] ElotuzumabTumour lysis syndrome and acute renal failure: case report
Reactions Weekly, 2018, 1686 (1) : 158 - 158
[8] Rituximab/vincristineTumour lysis syndrome and acute renal failure: case report
Reactions Weekly, 2021, 1839 (1) : 277 - 277
[9] SunitinibTumour lysis syndrome leading to acute renal failure: case report
Reactions Weekly, 2011, 1372 (1) : 32 - 32
[10] Cyclophosphamide/prednisoloneTumour lysis syndrome and acute renal failure: case report
Reactions Weekly, 2010, 1317 (1) : 19 - 19

← 1 2 3 4 5 →